Cytogenetically invisible microdeletions involving PITX2 in Rieger syndrome

Engenheiro, E.; Saraiva,, J.; Carreira, I.; Ramos, L.; Ropers, Hans-Hilger; Silva, E.; Tommerup, N.; Tümer, Z.

doi:10.1111/j.1399-0004.2007.00879.x

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Cytogenetically invisible microdeletions involving PITX2 in Rieger syndrome

MPS-Authors

/persons/resource/persons50501

Ropers, Hans-Hilger
Dept. of Human Molecular Genetics (Head: Hans-Hilger Ropers), Max Planck Institute for Molecular Genetics, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Engenheiro, E., Saraiva, J., Carreira, I., Ramos, L., Ropers, H.-H., Silva, E., et al. (2007). Cytogenetically invisible microdeletions involving PITX2 in Rieger syndrome. Clinical Genetics: an International Journal of Genetics in Medicine, 72(5), 464-470. doi:10.1111/j.1399-0004.2007.00879.x.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0010-81A1-8

Abstract

Axenfeld–Rieger syndrome (ARS) is a genetically heterogeneous autosomal dominant disorder mainly characterized by developmental defects of the anterior segment and extraocular anomalies. ARS shows great clinical variability and encompasses several conditions with overlapping phenotypes, including Rieger syndrome (RS). RS is characterized by developmental defects of the eyes, teeth and umbilicus, and the main causative gene is PITX2 (paired-like homeodomain transcription factor 2, or RIEG1) at 4q25. PITX2 mutations show great variety, from point mutations to microscopic or submicroscopic deletions, and apparently balanced translocations in few cases. We identified cytogenetically undetectable submicroscopic deletions at 4q25 in two unrelated patients diagnosed with RS. One patient had a t(4;17)(q25;q22)dn translocation with a deletion at the 4q breakpoint, and the other patient had an interstitial deletion of 4q25. Both deletions included only the PITX2 and ENPEP (glutamyl aminopeptidase) genes.